Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: A systematic review and meta-analysis

被引：0
|
作者：
Schipilliti, F. M. [1 ]
Rizzo, A. [2 ]
Di Costanzo, F. [3 ]
Acquafredda, S. [4 ]
Arpino, G. [5 ]
Puglisi, F. [6 ]
Del Mastro, L. [7 ]
Montemurro, F. [8 ]
De Laurentiis, M. [9 ]
Giuliano, M. [10 ]
机构：
[1] St Andrea Univ Hosp, Dept Oncol, Rome, Italy
[2] Ist Tumori Bari Giovanni Paolo II IRCCS, Dept Oncol, Bari, Italy
[3] Azienda Osped Univ Federico II, Oncol Med, Naples, Italy
[4] Policlin Bari Osped Giovanni XXIII, Dipartimento Oncol, Bari, Italy
[5] Univ Napoli Federico II, Dept Oncol, Dipartimento Farm, Naples, Italy
[6] Osped S Maria Misericordia, Dept Med Oncol, ASU Friuli Cent, Udine, Pordenone, Italy
[7] IRCCS Osped Policlin San Martino, Dept Internal Med, Genoa, Italy
[8] IRCCS Ist Candiolo FPO, Investigat Clin Oncol Dept, Candiolo, TO, Italy
[9] Ist Nazl Tumori IRCCS Fdn G Pascale, Dept Breast & Thorac Oncol, Naples, Italy
[10] AOU Federico II, Dept Oncol, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.463
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
266P
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant chemoimmunotherapy in early triple-negative breast cancer: a new kid on the block?
    Rizzo, Alessandro
    Palmiotti, Gennaro
    IMMUNOTHERAPY, 2022, 14 (10) : 755 - 758
  • [32] Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis
    Sternschuss, Michal
    Yerushalmi, Rinat
    Saleh, Ramy R.
    Amir, Eitan
    Goldvaser, Hadar
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (11) : 3369 - 3379
  • [33] Comparative efficacy and safety of first-line neoadjuvant treatments in triple-negative breast cancer: systematic review and network meta-analysis
    Jinming Li
    Guoshuang Shen
    Miaozhou Wang
    Xingfa Huo
    Fuxing Zhao
    Dengfeng Ren
    Yi Zhao
    Jiuda Zhao
    Clinical and Experimental Medicine, 2023, 23 : 1489 - 1499
  • [34] Comparative efficacy and safety of first-line neoadjuvant treatments in triple-negative breast cancer: systematic review and network meta-analysis
    Li, Jinming
    Shen, Guoshuang
    Wang, Miaozhou
    Huo, Xingfa
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Yi
    Zhao, Jiuda
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (05) : 1489 - 1499
  • [35] Predictive value of tumor-infiltrating lymphocytes for neoadjuvant therapy response in triple-negative breast cancer: A systematic review and meta-analysis
    Sun, Hai-Kuan
    Jiang, Wen-Long
    Zhang, Shi-Lei
    Xu, Peng-Cheng
    Wei, Li-Min
    Liu, Jiang-Bo
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (07):
  • [36] Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis
    Michal Sternschuss
    Rinat Yerushalmi
    Ramy R. Saleh
    Eitan Amir
    Hadar Goldvaser
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 3369 - 3379
  • [37] Prognostic Value of Differentially Expressed LncRNAs in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
    Tuluhong, Dilihumaer
    Dunzhu, Wangmu
    Wang, Jingjie
    Chen, Tao
    Li, Hanjun
    Li, Qiurong
    Wang, Shaohua
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2020, 30 (05): : 447 - 456
  • [38] Risk of having BRCA mutations in women with triple-negative breast cancer: A systematic review and meta-analysis
    Tun, N. M.
    Villani, G. M.
    Ong, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [39] Neoadjuvant Chemoimmunotherapy for NSCLC A Systematic Review and Meta-Analysis
    Sorin, Mark
    Prosty, Connor
    Ghaleb, Louis
    Nie, Kathy
    Katergi, Khaled
    Shahzad, Muhammad H.
    Dube, Laurie-Rose
    Atallah, Aline
    Swaby, Anikka
    Dankner, Matthew
    Crump, Trafford
    Walsh, Logan A.
    Fiset, Pierre O.
    Sepesi, Boris
    Forde, Patrick M.
    Cascone, Tina
    Provencio, Mariano
    Spicer, Jonathan D.
    JAMA ONCOLOGY, 2024, : 621 - 633
  • [40] Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis
    Singh-Phulgenda, Sauman
    Dahal, Prabin
    Ngu, Roland
    Maguire, Brittany J.
    Hawryszkiewycz, Alice
    Rashan, Sumayyah
    Brack, Matthew
    Halleux, Christine M.
    Alves, Fabiana
    Stepniewska, Kasia
    Olliaro, Piero L.
    Guerin, Philippe J.
    PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (03):
12345